Vistagen Therapeutics, Inc.

VTGN·NASDAQ·$0.64Share Price as of 11/2·$21MMarket Cap as of 11/2

Financials

10-QQ1 ended 06/30/2608/14/26 10-KFY 202606/15/26 10-QQ3 ended 12/31/2502/12/26 10-QQ2 ended 09/30/2511/13/25 10-QQ1 ended 06/30/2508/07/25

Disclosures

8-KCurrent report10/30/26 8-KCurrent report10/09/26 8-KCurrent report09/25/26 8-KCurrent report09/24/26 8-KCurrent report09/22/26

Prospectuses and Registrations

424B5Prospectus supplement06/17/25 S-8Registration of securities for employees06/17/24 S-3Shelf registration02/13/24 424B5Prospectus supplement10/03/23 424B5Prospectus supplement08/08/23

Proxies

DEF 14ADefinitive proxy07/31/26 DEFA14AAdditional proxy materials07/31/26 DEF 14ADefinitive proxy07/28/25 DEFA14AAdditional proxy materials07/28/25 DEF 14ADefinitive proxy07/17/24

Ownership

SC 13G/ABeneficial ownership (amended)08/14/26 SC 13G/ABeneficial ownership (amended)08/14/26 SC 13G/ABeneficial ownership (amended)08/14/26 Form 3Initial insider ownership07/31/26 Form 4Insider transaction07/31/26

Other

EFFECTRequest for effectiveness02/29/24 CORRESPCorrespondence with the SEC02/27/24 UPLOADLetter from the SEC02/16/24 EFFECTRequest for effectiveness03/21/23 CORRESPCorrespondence with the SEC03/17/23